Amocarzine

This classification denotes an antihelminthic agent with the molecular formula C18H21N5O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99807U412Y, chemically known as 1-piperazinecarbothioamide, 4-methyl-n-(4-((4-nitrophenyl)amino)phenyl)- but generally known as amocarzine, which bears US NIH Compound Identifier 5464102. European Medicines Agency schedules Amocarzine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05469MIG. The term AMOCARZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). AMOCARZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amocarzine under HS 29335995 and SITC 51576. As of Q4 2014, AMOCARZINE remains the US FDA Preferred Term for this commodity. Amocarzine bears US NLM identifiers UMLS ID C0164697 and NCI Concept Code C72145. SMILES: S=C(N1CCN(CC1)C)NC1CCC(NC2CCC([N](=O)O)CC2)CC1.